tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sarepta Therapeutics: Positioned for Growth Amidst Elevidys Uptake and Portfolio Diversification
PremiumRatingsSarepta Therapeutics: Positioned for Growth Amidst Elevidys Uptake and Portfolio Diversification
21d ago
Sarepta upgraded to Outperform from Market Perform at BMO Capital
Premium
The Fly
Sarepta upgraded to Outperform from Market Perform at BMO Capital
21d ago
Sarepta price target raised to $15 from $12 at Leerink
Premium
The Fly
Sarepta price target raised to $15 from $12 at Leerink
1M ago
Elanco to replace Sarepta in S&P 400 at open on 9/2
PremiumThe FlyElanco to replace Sarepta in S&P 400 at open on 9/2
2M ago
Sarepta to replace Brookline Bancorp in S&P 600 at open on 9/2
Premium
The Fly
Sarepta to replace Brookline Bancorp in S&P 600 at open on 9/2
2M ago
Sarepta financing net negative for equity holders, says H.C. Wainwright
Premium
The Fly
Sarepta financing net negative for equity holders, says H.C. Wainwright
2M ago
BofA trims Sarepta price target, says debt refinancing mitigates liquidity risk
PremiumThe FlyBofA trims Sarepta price target, says debt refinancing mitigates liquidity risk
2M ago
Sarepta refinances $700M of convertible notes, extends maturities to 2030
Premium
The Fly
Sarepta refinances $700M of convertible notes, extends maturities to 2030
2M ago
Sarepta Therapeutics Restructures Debt with New Convertible Notes
Premium
Company Announcements
Sarepta Therapeutics Restructures Debt with New Convertible Notes
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100